Table 2. Univariate and multivariate analysis of prognostic factors in HCC for disease-free survival.

	Univariate analysis			Multivariate analysis
	HR	p > |z|	95% CI	HR	p > |z|	95% CI
MAGE-A9 expression
High versus Low	3.39	0.001*	1.898–6.046	2.54	0.006*	1.299–4.954
Gender
Male versus Female	1.08	0.648	0.580–2.403
Age (years)
<60 versus ≥60	1.66	0.146	0.838–3.285
Tumour size (cm)
>5 versus ≤5	1.83	0.031*	1.057–3.177	1.44	0.255	0.768–2.707
α-fetoprotein status
High versus Low	1.01	0.971	0.603–1.692
Hepatitis B virus infection
Positive versus Negative	1.21	0.486	0.699–2.128
Liver cirrhosis
Positive versus Negative	0.89	0.660	0.522–1.509
Pathological grade
Grade 1 and 2 versus Grade 3	0.45	0.007*	0.252–0.807	0.74	0.378	0.384–1.438
Portal vein invasion
Positive versus Negative	3.26	0.001*	1.930–5.520	1.79	0.073	0.948–3.368
Lymph node metastasis
Positive versus Negative	2.67	0.001*	1.548–4.605	2.29	0.008*	1.238–4.229
Distant metastasis
Positive versus Negative	2.52	0.035*	1.068–5.966	0.60	0.317	0.216–1.644
TNM stage
Stage I-II versus Stage III-IV	0.32	0.001*	0.184–0.565	0.77	0.480	0.370–1.598
MAGE-A9 expression+ α-fetoprotein status
Both high versus Others situations (High + Low or Low + High or Both low)	1.60	0.093	0.925–2.785

*p < 0.05.